AU9130298A - Method of increasing bone volume - Google Patents

Method of increasing bone volume Download PDF

Info

Publication number
AU9130298A
AU9130298A AU91302/98A AU9130298A AU9130298A AU 9130298 A AU9130298 A AU 9130298A AU 91302/98 A AU91302/98 A AU 91302/98A AU 9130298 A AU9130298 A AU 9130298A AU 9130298 A AU9130298 A AU 9130298A
Authority
AU
Australia
Prior art keywords
naturally
occurring
agonist
bone
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU91302/98A
Other languages
English (en)
Inventor
Mitchell Anthony Delong
James Richard Hartke
Mark Walden Lundy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU9130298A publication Critical patent/AU9130298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU91302/98A 1997-09-09 1998-09-04 Method of increasing bone volume Abandoned AU9130298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5821897P 1997-09-09 1997-09-09
US60058218 1997-09-09
PCT/US1998/018337 WO1999012550A1 (en) 1997-09-09 1998-09-04 Method of increasing bone volume

Publications (1)

Publication Number Publication Date
AU9130298A true AU9130298A (en) 1999-03-29

Family

ID=22015432

Family Applications (1)

Application Number Title Priority Date Filing Date
AU91302/98A Abandoned AU9130298A (en) 1997-09-09 1998-09-04 Method of increasing bone volume

Country Status (17)

Country Link
EP (1) EP1035853A1 (es)
JP (1) JP2001515863A (es)
CN (1) CN1269720A (es)
AR (1) AR013478A1 (es)
AU (1) AU9130298A (es)
BR (1) BR9811775A (es)
CA (1) CA2303799A1 (es)
CO (1) CO5070621A1 (es)
HU (1) HUP0003584A3 (es)
ID (1) ID24759A (es)
IL (1) IL134759A0 (es)
NO (1) NO20001172L (es)
PE (1) PE118899A1 (es)
PL (1) PL339297A1 (es)
SK (1) SK3402000A3 (es)
WO (1) WO1999012550A1 (es)
ZA (1) ZA988229B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0200258A2 (hu) 1999-03-05 2002-05-29 The Procter & Gamble Co. C16-telítetlen FP-szelektív prosztaglandin analógok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3607293A (en) * 1992-02-05 1993-09-03 Merck & Co., Inc. Implant therapy for bone growth stimulation
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
WO1999012550A1 (en) 1999-03-18
SK3402000A3 (en) 2000-12-11
PE118899A1 (es) 2000-02-03
ID24759A (id) 2000-08-03
AR013478A1 (es) 2000-12-27
JP2001515863A (ja) 2001-09-25
BR9811775A (pt) 2000-08-29
PL339297A1 (en) 2000-12-04
EP1035853A1 (en) 2000-09-20
CN1269720A (zh) 2000-10-11
CA2303799A1 (en) 1999-03-18
HUP0003584A2 (hu) 2001-02-28
NO20001172L (no) 2000-05-08
NO20001172D0 (no) 2000-03-07
ZA988229B (en) 1999-03-09
CO5070621A1 (es) 2001-08-28
HUP0003584A3 (en) 2002-12-28
IL134759A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
US6156799A (en) Method of increasing bone volume using non-naturally-occurring FP selective agonists
US20210346469A1 (en) Compositions and Methods for Increasing Insulin Sensitivity
JPH09505809A (ja) ヒドロキシカルバゾール化合物類による平滑筋移動および増殖の阻害
KR20060128995A (ko) 체중감량에 영향을 미치는 항경련제와 항정신병 약물의조성물
US20030181515A1 (en) Methods of using kavalactone compositions
JPWO2003007991A1 (ja) Ｌｐａ受容体調節剤からなる膵液分泌制御剤
US5958884A (en) Compositions and methods for treating erectile dysfunction
US6534534B1 (en) Pharmaceutical composition active in reducing production of MCP-1 protein
US6844361B2 (en) Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
AU9130298A (en) Method of increasing bone volume
AU3711900A (en) Method of increasing bone volume using non-naturally-occurring ep1 selective agonists
WO2000051616A1 (en) Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives
WO2000041700A1 (en) Use of estrogens and delta-gonadien-21-ol-3,20-diones in the treatment or prophylaxis of cerebral degenerative disorders
MXPA00002395A (es) Metodo para incrementar el volumen oseo
MXPA00002394A (es) Metodo para incrementar el volumen oseo usando agonistas selectivos de prostanoide f no naturales
DE69928685T2 (de) Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit
JPH1135470A (ja) ビタミンｄ３誘導体を含有する副甲状腺ホルモン産生促進剤
CZ2000808A3 (cs) Použití selektivního FP agonisty, který se přirozeně nevyskytuje
JP2002538122A (ja) 天然に存在しないｆｐ選択的アゴニストおよび骨吸収抑制化合物を用いる骨体積の増加方法
WO2011000562A1 (en) Eltoprazine for the treatment of certain movement disorders

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted